Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study: Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface

NCT05302609 is registered in ClinicalTrials.gov with TBF Genie Tissulaire as lead sponsor.

NCT NCT05302609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05302609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study: Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface
Lead sponsor
TBF Genie Tissulaire
Phase
Phase 2
Overall status
Terminated
Start date
July 4, 2022
Completion date
February 21, 2024
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

scleral thinning